The use of biologics in pregnant patients with rheumatic disease

Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy

(2016) Wai-Kay Seto et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

(2016) Carina Götestam Skorpen et al.   ANNALS OF THE RHEUMATIC DISEASES

Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy

(2016) Gabriella Bröms et al.   Clinical Gastroenterology and Hepatology

The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response

(2016) Sarah Sheibani et al.   DIGESTIVE DISEASES AND SCIENCES

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

(2016) Mette Julsgaard et al.   GASTROENTEROLOGY

Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients

(2016) Frauke Förger et al.   JOINT BONE SPINE

Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer

(2016) Charlene Porter et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry

(2016) S. H. M. Manders et al.   JOURNAL OF RHEUMATOLOGY

Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care

(2016) I N Bruce et al.   LUPUS

Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data

(2016) Maria Hoeltzenbein et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report

(2016) Giacomo Emmi et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

State of the art: Reproduction and pregnancy in rheumatic diseases

(2015) Monika Østensen et al.   AUTOIMMUNITY REVIEWS

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study

(2015) Corinna Weber-Schoendorfer et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

(2015) Darren M. Roberts et al.   JOURNAL OF AUTOIMMUNITY

Monoclonal Antibodies, Systemic Lupus Erythematosus, and Pregnancy: Insights from an Open-label Study

(2015) V. K. SANDHU et al.   JOURNAL OF RHEUMATOLOGY

Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review

(2015) T. M. Kuijper et al.   JOURNAL OF RHEUMATOLOGY

Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol

(2015) M. E. B. Clowse et al.   JOURNAL OF RHEUMATOLOGY

Pregnancy outcomes following exposure to abatacept during pregnancy

(2015) Monica Kumar et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

(2015) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare

(2015) Huifeng Yun et al.   Arthritis & Rheumatology

OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials

(2014) M. Powell et al.   ANNALS OF THE RHEUMATIC DISEASES

Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester

(2014) Claire Sheeran et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

(2014) J. Westra et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Belimumab for the treatment of systemic lupus erythematosus

(2014) Natasha Jordan et al.   Expert Review of Clinical Immunology

Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children

(2014) Martin Bortlik et al.   INFLAMMATORY BOWEL DISEASES

Anti-TNF-  Therapy May Cause Neonatal Neutropenia

(2014) T. Guiddir et al.   PEDIATRICS

Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report

(2014) Abhijeet Danve et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis

(2014) J. R. Curtis et al.   ARTHRITIS CARE & RESEARCH

Brief Report: Anakinra Use During Pregnancy in Patients With Cryopyrin-Associated Periodic Syndromes

(2014) Zenas Chang et al.   Arthritis & Rheumatology

Fetal outcomes after rituximab exposure in women with autoimmune vasculitis

(2013) William F Pendergraft et al.   ANNALS OF THE RHEUMATIC DISEASES

Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases

(2013) Mario Ojeda-Uribe et al.   CLINICAL RHEUMATOLOGY

B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases

(2013) Shirish R. Sangle et al.   JOURNAL OF AUTOIMMUNITY

From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti–tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis

(2013) Kiran Motaparthi et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases

(2013) M. Jani et al.   RHEUMATOLOGY

Treating inflammation by blocking interleukin-1 in humans

(2013) Charles A. Dinarello et al.   SEMINARS IN IMMUNOLOGY

Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis

(2012) Thierry Dervieux et al.   ANNALS OF THE RHEUMATIC DISEASES

The Effects of Interleukin-6 Signal Blockade on Fertility, Embryo-fetal Development, and Immunization In vivo

(2012) Takayuki Sakurai et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

(2012) Zuzana Zelinkova et al.   Clinical Gastroenterology and Hepatology

Abatacept therapy and safety management

(2012) Thao Pham et al.   JOINT BONE SPINE

Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31

(2011) Casper Steenholdt et al.   Journal of Crohns & Colitis

The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population

(2011) H. J. M. J. CRIJNS et al.   JOURNAL OF RHEUMATOLOGY

Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation

(2010) Pauline L. Martin et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Pregnancy outcomes after maternal exposure to rituximab

(2010) E. F. Chakravarty et al.   BLOOD

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR

(2010) Takuo Suzuki et al.   JOURNAL OF IMMUNOLOGY

Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys

(2010) Anu Vaidyanathan et al.   TOXICOLOGICAL SCIENCES

Neutropenia in patients receiving anti-tumor necrosis factor therapy

(2010) Richard Hastings et al.   ARTHRITIS CARE & RESEARCH

Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases

(2009) Michael Elliott et al.   Annals of the New York Academy of Sciences

Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum

(2009) A Murashima et al.   ANNALS OF THE RHEUMATIC DISEASES

A patient's wish: anakinra in pregnancy

(2009) C T Berger et al.   ANNALS OF THE RHEUMATIC DISEASES

A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database

(2009) J. D. CARTER et al.   JOURNAL OF RHEUMATOLOGY

Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator

(2009) Diana J. Auyeung-Kim et al.   REPRODUCTIVE TOXICOLOGY

Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development

(2008) D. T. Klink et al.   Clinical & Developmental Immunology

499 The Effect of Maternal Peripartum Infliximab Use On Neonatal Immune Response

(2008) Uma Mahadevan et al.   GASTROENTEROLOGY